Web NewDrugInformation.com

Vanos Drug - Vanos The trade name of the product as shown on the labeling. Dosage - CREAM; TOPICAL The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Fluocinonide Multiple ingredients are in alphabetical order. Strength - 0.1% The potency of the active ingredient(s), Fluocinonide. May repeat for multiple part products. Applicant - MEDICIS The firm name holding legal responsibility for Vanos. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 021758 The FDA assigned number to Vanos. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Vanos. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Feb 11, 2005 The date Vanos was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - Yes The pioneer or innovator of Vanos. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Vanos is in. Format is RX, OTC, DISCN. Applicant Full Name - Medicis Pharmaceutical Corp The full name of the firm holding legal responsibility for the new application of Vanos. Vanos Fluocinonide Emulsified Base 0.05% Cream; Topical Fluocinonide Emulsified Base 0.05% Cream; Topical Fluocinonide Emulsified Base 0.05% Cream; Topical Lidex 0.05% Cream; Topical Lidex-e 0.05% Cream; Topical Vanos 0.1% Cream; Topical Fluocinonide 0.05% Cream; Topical Fluocinonide 0.05% Cream; Topical Fluocinonide 0.05% Cream; Topical Fluocinonide Emulsified Base 0.05% Cream; Topical NewDrugInformation